LIVE·NEON · 1,211 CONTRACTS
ContractLocal CCP

H4523·CVS Health Corporation

HMO/HMOPOS · observed 2026 → 2026 · 75 months of CPSC history · 18 active CY 2026 plans.

Latest enrollment
36.2K
2026-05
Months of data
75
History range
2020-01 → 2026-05
CY 2026 plans
18
01 · Trend

Monthly enrollment

fact_enrollment_cpsc · 75 months
36,23911,299
02 · Plans

CY 2026 plan roster

fact_landscape ⋈ fact_enrollment_cpsc · 18 plans
PlanCategoryPremiumMOOPCountiesEnrollment
Aetna Medicare Prime Care (HMO)
H4523/024
MA-PD$0$4,2004.019,627
Aetna Medicare Signature Extra (HMO)
H4523/015
MA-PD$0$6,7504.0106,000
Aetna Medicare Signature Extra (HMO)
H4523/001
MA-PD$0$3,8004.0114,857
Aetna Medicare Prime Care (HMO)
H4523/021
MA-PD$0$4,2004.033,198
Aetna Medicare Full Dual Care (HMO D-SNP)
H4523/034 · Dual-Eligible
SNP$0$9,2504.0832,051
Aetna Medicare Prime Chronic Care (HMO C-SNP)
H4523/037 · Chronic or Disabling Condition
SNP$0$6,7504.021,849
Aetna Medicare Prime Care (HMO)
H4523/020
MA-PD$0$3,8004.021,757
Aetna Medicare Partial Dual Care (HMO D-SNP)
H4523/043 · Dual-Eligible
SNP$5$9,2504.0191,461
Aetna Medicare Full Dual Care (HMO D-SNP)
H4523/029 · Dual-Eligible
SNP$0$9,2504.0191,173
Aetna Medicare Prime Chronic Total (HMO C-SNP)
H4523/039 · Chronic or Disabling Condition
SNP$4$9,2504.031,038
Aetna Medicare Partial Dual Care (HMO D-SNP)
H4523/044 · Dual-Eligible
SNP$0$9,2504.021985
Aetna Medicare Full Dual Care (HMO D-SNP)
H4523/030 · Dual-Eligible
SNP$0$9,2504.021776
Aetna Medicare Prime Chronic Care (HMO C-SNP)
H4523/038 · Chronic or Disabling Condition
SNP$0$6,7504.02349
Aetna Medicare Signature Care (HMO)
H4523/027
MA-PD$0$4,1504.05297
Aetna Medicare Signature (HMO)
H4523/031
MA-PD$0$9,2504.01249
Aetna Medicare Partial Dual Care (HMO D-SNP)
H4523/041 · Dual-Eligible
SNP$5$9,2504.080238
Aetna Medicare Full Dual (HMO D-SNP)
H4523/028 · Dual-Eligible
SNP$0$9,2504.03145
Aetna Medicare Signature (HMO)
H4523/042
MA-PD$0$9,2504.0131
03 · Quality

Star Ratings · contract-level

fact_star_ratings · 2 years
Star scale · 1.0 – 5.0★ summary
1.02.03.04.05.0202520264.04.03.54.04.03.5
  • Overall
    4.04.0
    0.020252026
  • Part C
    3.54.0
    +0.520252026
  • Part D
    4.03.5
    -0.520252026
Measure breakdown · CY 2026 · 45 measures
IDMeasure
C01Breast Cancer Screening3.0
C02Colorectal Cancer Screening4.0
C03Annual Flu Vaccine4.0
C04Improving or Maintaining Physical Health3.0
C05Improving or Maintaining Mental Health4.0
C06Monitoring Physical Activity3.0
C07Special Needs Plan (SNP) Care Management
C08Care for Older Adults – Medication Review
C09Care for Older Adults – Pain Assessment
C10Osteoporosis Management in Women who had a Fracture3.0
C11Diabetes Care – Eye Exam4.0
C12Diabetes Care – Blood Sugar Controlled5.0
C13Kidney Health Evaluation for Patients with Diabetes4.0
C14Controlling High Blood Pressure3.0
C15Reducing the Risk of Falling3.0
C16Improving Bladder Control2.0
C17Medication Reconciliation Post-Discharge5.0
C18Plan All-Cause Readmissions4.0
C19Statin Therapy for Patients with Cardiovascular Disease4.0
C20Transitions of Care3.0
C21Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions3.0
C22Getting Needed Care4.0
C23Getting Appointments and Care Quickly4.0
C24Customer Service3.0
C25Rating of Health Care Quality5.0
C26Rating of Health Plan4.0
C27Care Coordination4.0
C28Complaints about the Health Plan4.0
C29Members Choosing to Leave the Plan3.0
C30Health Plan Quality Improvement3.0
C31Plan Makes Timely Decisions about Appeals4.0
C32Reviewing Appeals Decisions5.0
C33Call Center – Foreign Language Interpreter and TTY Availability4.0
D01Call Center – Foreign Language Interpreter and TTY Availability5.0
D02Complaints about the Drug Plan4.0
D03Members Choosing to Leave the Plan3.0
D04Drug Plan Quality Improvement2.0
D05Rating of Drug Plan4.0
D06Getting Needed Prescription Drugs4.0
D07MPF Price Accuracy5.0
D08Medication Adherence for Diabetes Medications3.0
D09Medication Adherence for Hypertension (RAS antagonists)3.0
D10Medication Adherence for Cholesterol (Statins)3.0
D11MTM Program Completion Rate for CMR5.0
D12Statin Use in Persons with Diabetes (SUPD)4.0